Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest reportUrenco CEO, Boris Schucht, has been elected as a Board member of the World Nuclear Association (WNA).
Boris will take up his post after the WNA Board meeting today (14 April). He will join esteemed colleagues from across the nuclear industry whose mission is to promote a wider understanding of nuclear energy among key international influencers; develop common industry positions, and contribute to the energy debate. All of which align to Urenco’s own regulatory roadmap objectives and specific advocacy goals within our sustainability programme.
Nuclear Week in Parliament sees MPs and Peers gather to discuss nuclear energy with industry.
Read more MP event told of ‘defining moment’ for nuclearNuclear Week in Parliament sees MPs and Peers gather to discuss nuclear energy with industry.
Read more MP event told of ‘defining moment’ for nuclearWe have extended a social impact partnership which will result in new professionals teaching students science, technology, engineering and maths related subjects.
Read more Urenco backs training of more STEM teachersWe have extended a social impact partnership which will result in new professionals teaching students science, technology, engineering and maths related subjects.
Read more Urenco backs training of more STEM teachersAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries